Septerna, Inc. (SEPN) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US81734D1046
Septerna, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 45.95 m USD |
| Operating income | -68.30 m USD |
| EBIT | -68.40 m USD |
| Net income | -48.88 m USD |
| Diluted EPS – continuing operations | -1.10 USD |
Full history since 2022, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Septerna, Inc.
Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. It develops PTH1R Program, oral small molecule Parathyroid Hormone 1 Receptor agonists for the treatment of hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 negative allosteric modulator (NAM) for chronic spontaneous urticaria and other mast cell diseases; and TSHR Program, an oral small molecule TSHR NAM for graves' disease and thyroid eye disease. In addition, it focuses on other therapeutic areas, including neurology, women's health, cardiovascular disease, and respiratory disease. It has global collaboration and license agreement with Novo Nordisk to discover, develop and commercialize multiple potential oral small molecule therapies for metabolic-related diseases based on certain specified molecular targets. The company was formerly known as GPCR NewCo, Inc. and changed its name to Septerna Inc. in June 2021. Septerna, Inc. was incorporated in 2019 and is headquartered in South San Francisco, California.
More stocks
- Netmarble Games Corp (251270.KS)
- Chung-Hsin Electric & Machinery Mfg Corp (1513.TW)
- Lovisa Holdings Ltd (LOV.AX)
- Cosan SA ADR (CSAN)
- Porch Group, Inc. (PRCH)
- Kinnevik Investment AB ser. A (KINV-A.ST)
- Shanghai Baosight Software Co Ltd B (900926.SS)
- Drägerwerk AG & Co. KGaA (pref) (DRW3.DE)
- XiaMen HongXin Electron-tech Co Ltd (300657.SZ)
- GCL System Integration Technology Co Ltd (002506.SZ)
- L1 Group Ltd (L1G.AX)
- CNNC Hua Yuan Titanium Dioxide Co Ltd (002145.SZ)
Not investment advice. All data without warranty, price as of 02.11.2026. Details in the risk notice.